No Link Between Diabetes Drug And Pancreatic Cancer Found

Irving, TX  Type 2 diabetics struggling to keep their blood sugar levels under control by using incretin-based medications can breathe a sigh of relief. A recent study has concluded that these drugs do not increase the risk for pancreatic cancer forming.

The potential link between incretin-based drugs and increased pancreatic cancer risks was especially troubling for diabetics who already find themselves at higher risk for this disease, explains Dr. Gregory Echt, one of the physicians behind the Sandler-Kenner Foundation and the founder and lead surgeon at Choice Cancer Care. Research has shown, however, that a link between the two does not appear to exist. This is especially important because incretin-based drugs are used to help treat nearly 1 million type 2 diabetics and have been proven to be quite useful in keeping diabetes in check.

Pancreatic cancer is known to be among the deadliest forms of the disease. With a five-year survival rate that is less than 10 percent, preventative measures, when applicable are seen as especially important. Risks for pancreatic cancer include diabetes, chronic pancreatitis, gallstones and smoking, among others. Often presenting with no or few symptoms, pancreatic cancer can be difficult to diagnose in its earlier, more treatable phases. An estimated 53,000 Americans are diagnosed with the disease annually. About 41,000 die from it each year.

While incretin-based drugs do not appear to increase pancreatic cancer risks, diabetics should discuss the disease and their likelihood of developing it with their healthcare providers, says Dr. Echt. Understanding the signs, symptoms and other measures that can be taken to lower risks can be very important.

To find out more about pancreatic cancer and steps that are being taken to fight it, visit the Sandler-Kenner Foundation online. The nonprofit organization is dedicated to helping advance research that may one day lead to a cure for pancreatic cancer.

About The Sandler-Kenner Foundation
The Sandler-Kenner Foundation, established in 2007 as the Las Colinas Cancer Center Foundation, was renamed in early 2011 in the memory of Michael Sandler and Peter Kenner, both of whom passed away from pancreatic cancer, a lethal disease that is difficult to diagnose until it has reached an advanced stage.

Company :-Sandler-Kenner Foundation

User :- Hollie Williams

Email :-erwindale.ed@gmail.com

Phone :-214-379-2779

Mobile:- -

Url :- http://helpfightpancreaticcancer.org/